Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
JAMIA Open|October 6, 2025
Synthetic data for pharmacogenetics: enabling scalable and secure researchMarko Miletic, Anna Bollinger, Samuel S Allemann, et al.BMC Anesthesiology|November 16, 2024
Pharmacogenotyping disproves genetic cause of drug-related problems in family history: a case reportAnna Bollinger, Kurt E Hersberger, Henriette E Meyer Zu Schwabedissen, et al.Journal of Pain Research|September 12, 2025
A Swiss Cross-Sectional Study on Patients' Perspectives on Chronic Pain Management, Analgesic Treatment, and Genetic SusceptibilityAnna Bollinger, Céline K Stäuble, Isabelle O Urdieux, et al.Pain Reports|February 25, 2025
Analgesic therapy failure in a <i>COMT</i> HPS/HPS diplotype carrier heterozygous for the <i>CYP2D6</i> *<i>4</i> allele with fibromyalgia-a case reportAnna Bollinger, Julia Gianora, Tanja Schüpbach, et al.Pharmacogenomics|September 15, 2023
Severe systemic adverse reactions to ophthalmic timolol in a <i>CYP2D6</i> homozygous <i>*4</i> allele carrier: a case reportAnna Bollinger, Chiara Jeiziner, Henriette E Meyer Zu Schwabedissen, et al.Pharmacy (Basel, Switzerland)|February 25, 2025
Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions-A Longitudinal Mixed-Methods Study Exploring the Patient PerspectiveAnna Bollinger, Melissa Semedo Fortes, Henriette E Meyer Zu Schwabedissen, et al.Pharmacogenomics and Personalized Medicine|July 10, 2023
Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series StudyAnna Bollinger, Céline K Stäuble, Chiara Jeiziner, et al.BMC Medical Genomics|December 19, 2024
Associations between (pharmaco-)genetic markers and postoperative pain after inguinal hernia repair - a prospective study protocolFlorine M Wiss, Ulrich Dietz, Andreas Thalheimer, et al.Health Services Insights|July 14, 2025
Association of Pharmacogenotyping and Patient-Reported Outcomes in Chronic Pain ManagementAnna Bollinger, Kurt E Hersberger, Julia Gianora, et al.Clinical Pharmacology and Therapeutics|May 18, 2026
Biomarker-Based Prediction of OATP1B1 Activity in Clinical Routine-Investigating Coproporphyrins as Markers for Drug-Drug-Gene InteractionsLeila Potzel, Anina Zumtaugwald, Anna Bollinger, et al.Pageof 2